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In a study initially designed to evaluate reinnervation of
human cutaneous wounds using an antibody to the
neuroneal marker protein gene product (PGP) 9.5, we
observed marked immunostaining of cells with morpho-
logic features of fibroblasts in the wounds. PGP 9.5 has
recently been shown to be an important enzyme in the
highly conserved ubiquitin system of proteolysis. Because
the ubiquitin system is known to play an important role
in regulating the cell cycle, the presence of PGP 9.5 in
cells at a wound site was of considerable interest. Our
objectives were to clarify the time frame for the appear-
ance of PGP 9.5 and ubiquitin in wounds, to verify that
PGP 9.5 is produced by wound fibroblasts, and to evaluate
a potential role for these proteins in the tissue repair
process. Standard incisional human wounds were stained
with antibodies specific for PGP 9.5 and ubiquitin. At
7 d, stellate cells with morphologic features of fibroblasts
stained for PGP 9.5, whereas earlier wounds were gener-
ally negative. In 14 and 21 d incised wounds and in
Protein gene product 9.5 (PGP 9.5) is widely used as amarker for cutaneous innervation. The 26 kDa proteinwas isolated from brain tissue (Jackson and Thompson,1981) and subsequently shown to be an enzyme ofthe ubiquitin system (ubiquitin C-terminal hydrolase)
(Wilkinson et al, 1989).
Ubiquitin, an abundant 76-amino acid protein, is one of the most
phylogenetically conserved proteins known. The sequence is identical
in all animals and differs in yeast by only three amino acids (Ozkaynak
et al, 1987). Although phosphorylation is often a mechanism to change
the functional state of proteins, ubiquitinization targets proteins for
degradation. Ubiquitin mediated protein degradation plays a critical
role in cellular functions such as cell cycle control, DNA repair, and
stress responses (Finley and Chau, 1991). PGP 9.5 removes ubiquitin
from proteins undergoing degradation and allows recycling of free
ubiquitin from the conjugation products (Finley and Chau, 1991).
Relevant to the study of wounds, ubiquitination has been shown to
play a role in degradation of PDGF receptor-ligand complexes (Mori
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chronic granulation tissue from nonhealing ulcers there
was strong cellular staining for PGP 9.5 and for ubiquitin.
These stellate cells also showed expression of mRNA
for PGP 9.5 by reverse transcriptase-polymerase chain
reaction in situ hybridization. PGP 9.5 was detected
in cultured fibroblasts both by reverse transcriptase-
polymerase chain reaction and by northern blot analysis.
Confocal microscopy showed colocalization of antibodies
to PGP 9.5 and prolyl-4-hydroxylase (a fibroblast marker)
as well as colocalization of PGP 9.5 and the platelet
derived growth factor b receptor. We conclude that
ubiquitin and PGP 9.5 were expressed by fibroblasts
during the granulation tissue and remodeling phases
wound healing. The mRNA for PGP 9.5 was demon-
strated in stellate cells in chronic wounds and in fibroblasts
in culture. The appearance of these degradative proteins
in later wounds suggests a downregulation function in
the wound healing response. Key words: nerves/PGP 9.5/
ubiquitin/wound healing. J Invest Dermatol 111:565–572, 1998
et al, 1992). PDGF is known to stimulate both mitogenesis and
fibrogenesis in fibroblasts (Ross et al, 1986), which are key functions in
the wound healing process. Other cytokine receptor/ligand complexes
known to be important in wound healing undergo similar ubiquitin
mediated degradations (Mori et al, 1995). These include platelet derived
growth factor alpha-receptor, epidermal growth factor receptor, and
fibroblast growth factor-receptor.
In this study we observed marked immunostaining of PGP 9.5 in
cells with morphologic features of fibroblasts, particularly in mature
wounds (14 and 21 d). This was an unexpected finding because PGP
9.5 expression was originally thought to be quite specific for neuroneal
and neuroendocrine tissue (Thompson et al, 1983). PGP 9.5 has,
however, been detected using two-dimensional gel electrophoresis
or immunocytochemistry in non-neuroneal cells from renal distal
convoluted tubules, ovarian follicles, corpus luteum, and epididymal
epithelium, as well as in spermatogonia and Leydig cells (Wilson et al,
1988; Santamaria et al, 1993). Prior to our observations in human
fibroblasts,1 the only evidence that fibroblasts produce PGP 9.5 came
from two-dimensional immunoblotting, comigration, and micro-
sequencing of proteins recovered from human embryonal MRC-5
lung fibroblasts (Honore´ et al, 1991). More recently, DiPaolo et al
(1995) used similar two-dimensional immunoblotting techniques to
1Olerud JE, Gibran NS, Usui ML, Chiu DS, Ansel JC: PGP 9.5 and
ubiquitin immunostaining in human cutaneous wounds. J Invest Dermatol 4:421a,
1995 (abstr.)
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show the presence of PGP 9.5 in cultured human neonatal foreskin
fibroblasts.
We used immunocytochemistry (ICC) to document the presence of
both PGP 9.5 and ubiquitin in standard incisional wounds and in
chronic decubitus ulcers. Additionally, we wanted to determine if the
stellate cells were fibroblasts and whether they produced mRNA for
PGP 9.5 as well as expressing the protein. We questioned whether the
stellate cells showed coexpression of PGP 9.5 and platelet derived
growth factor β receptor (PDGFβ-r), because that would be consistent
with a potential mechanism of action in the wound healing process
involving degradation of one of the monomeric tyrosine kinase
receptors known to be important in wound healing. We used confocal
microscopy, transmission electron microscopy (TEM), northern blot
analysis, and reverse transcriptase-polymerase chain reaction (RT-PCR)
techniques for these studies.
MATERIALS AND METHODS
Standard human wounds and ulcers were studied Simplate-II (General
Diagnostics, Organon Teknika, NC) bleeding time devices were used to create
wounds on the arms and legs of normal male volunteers 66 6 6 y of age (mean
6 SD). The Simplate-II is a spring loaded instrument that, when activated,
projects a pair of blades 5 mm in length, 1 mm in depth, and 3 mm apart. This
human wound model has been previously described in detail (Olerud et al,
1995). Volunteers were recruited using methods approved by the University of
Washington Institutional Review Board for Human Subjects (UWIRBHS). All
subjects were screened and shown to be free of neuropathy and diabetes mellitus
as previously described (Olerud et al, 1995).
Two 4 mm punch biopsies were removed from wounds 1, 2, 3, 4, 7, 14,
and 21 d following injury. Half of each sample was fixed in half strength
Karnovsky’s fixative2 and then embedded in Epon 812 (Luft, 1961) for high
quality light microscopy and TEM. The other half was either fixed in 4%
paraformaldehyde/phosphate buffered saline (PBS) for 24 h and processed for
paraffin embedding or frozen in OCT (Tissue Tek, Miles, IN).
Chronic ulcers were studied. Six paraplegic subjects undergoing surgery to
excise and repair chronic sacral decubitus ulcers agreed to allow the study of
tissue removed during surgery. Consent was obtained using methods approved
by the UWIRBHS. Ulcer tissue was taken immediately upon excision, fixed
in 10% neutral buffered formalin, and processed for paraffin embedding or
frozen in OCT (Tissue Tek).
Immunostaining techniques (ICC) of wounds
To detect PGP 9.5 and ubiquitin in standard wounds and ulcers Six micron tissue
sections of the paraformaldehyde fixed wounds and the neutral buffered
formalin fixed ulcers, mounted on Superfrost Plus (Labcraft) glass slides, were
deparaffinized and processed for immunoperoxidase with the following solutions:
Tris buffered saline (TBS) washes, H2O2/TBS blocking (1%, 30 min), goat
serum/TBS blocking (1.3%, 30 min), polyclonal rabbit PGP 9.5 anti-serum
(Accurate Chemical Scientific, Westbury, NJ) at 1:1500 dilution for 1 h at
room temperature or polyclonal rabbit ubiquitin anti-serum (Dako, Carpenteria,
CA) at 1:250 dilution for 1 h. Diluent used for all antibodies was 0.1% bovine
serum albumin in TBS and all incubations were done at room temperature.
The secondary antibody was biotinylated goat anti-rabbit antibody (Vector
Laboratories, Burlingame, CA) at 1:200 dilution for 30 min, followed by avidin-
biotin complex (ABC Universal Kit, Zymed Laboratories, San Francisco, CA)
at 1:200 dilution for 30 min. Sections were then visualized for immunoreactivity
using 3,39 diaminobenzidine (Sigma, St. Louis, MO) as a chromogen (0.12%
in H2O, 20 min).
To detect PDGFβ-r in standard wounds Frozen sections of wounds washed in
TBS were post-fixed with 0.1% glutaraldehyde/TBS for 5 min. The slides were
processed as described above except that they were blocked with horse and
goat sera/TBS (3% and 1.3%, respectively, 30 min) and incubated with a
monoclonal mouse ascites PDGFβ-r antibody (Zymogenetics, Seattle, WA) at
1:1000 dilution for 1 h and secondary biotinylated horse anti-mouse (Vector
Laboratories) at 1:200 dilution for 30 min.
To identify wound fibroblasts using antibodies to prolyl-4-hydrolase (5B5) Frozen
sections of wounds were post-fixed in cold acetone for 5 min, washed in TBS,
and processed as above using a mouse monoclonal anti-human prolyl-4-
hydroxylase antibody (5B5) (Dako) at 1:100 dilution and biotinylated horse
anti-mouse IgG secondary antibody.
2Karnovsky MJ: A formaldehyde-glutaraldehyde fixative of high osmolarity
for use in electron microscopy. J Cell Biol 27:137a, 1965 (abstr.)
Fluorescence double-labeling
To demonstrate that PGP 9.5 and 5B5 are coexpressed by wound fibroblasts Frozen
sections were acetone fixed, washed in TBS, blocked with 1.3% goat and 0.3%
horse sera for 30 min, then incubated with PGP 9.5 antibody at 1:1000 dilution
and 5B5 antibody at 1:100 dilution for 1 h at room temperature. The diluent
for all antibodies contained 0.1% bovine serum albumin and 0.1% Tween 20
(polyoxyethlyenesorbitan monosaurate, Sigma). Sections were then sequencially
immunolabeled with a fluorescein-labeled goat anti-rabbit (Vector Laboratories)
at 1:200 dilution and biotinylated horse anti-mouse IgG (Vector Laboratories)
at 1:400 dilution for 30 min. Slides were rinsed in TBS and immunolabeled
with Texas Red Streptavidin (Vector Laboratories) at 1:1600 dilution for 30 min,
washed in TBS, then coverslipped using Vectashield (Vector Laboratories) as a
mounting medium.
To demonstrate that PGP 9.5 and PDGFβ-r are coexpressed by the same
cells Immunolabeling was as above except PDGFβ-r antibody was used (1:500)
in place of 5B5.
Laser scanning confocal microscopy
To visualize fluorescent double labeling Image acquisition for the fluorescence
double-labeling was on a BioRad MRC-600 confocal microscope equipped
with a krypton/argon mixed gas laser. The dual excitation mode was used,
passing 488 nm wavelength for fluoroscein isothiocyanate excitation and 568 nm
wavelength for Texas Red excitation. Dual image files were first split and then
imported into Adobe Photoshop for display purposes, with green for fluoroscein
isothiocyanate and red for Texas Red, and then superimposed to show
colocalization of label. Color prints were output to a Tektronix dye sublimation
printer at 300 dpi.
TEM
To evaluate ultrastructural features of stellate cells Standard 21 d wound specimens
that had been fixed directly in half strength Karnovsky’s fixative and processed
by standard methods for TEM were studied using a Phillips 420 transmission
electron microscope.
Detection of PGP-9.5 mRNA in cultured fibroblasts by RT-
PCR Oligonucleotide primers were synthesized (Bio-synthesis, Lewisville,
TX) corresponding to bp 170–190 59 primer, sense CAG CAT GAG AAC
TTC AGG AAA, and the complementary reverse sequence against bp 488–
508 39 primer, anti-sense GCC ATC CAC GTT GTT AAA CAG of PGP 9.5
cDNA as previously described (Day and Thompson, 1987). RNA was isolated
from cultured fibroblasts and reverse transcribed to make complementary cDNA
to PGP9.5.
PCR was performed on 0, 1, 2, and 5 µl of the preconfluent and confluent
RT reaction products by adding equal amounts of the 39 and 59 primers,
1.25 3 d4NTP mixture (Pharmacia LKB Biotechnology, Piscataway, NJ) and
10 3 PCR buffer 1 MgCl2 (Boehringer, Indianapolis, IN). Taq polymerase
(Boehringer) was added during the hot start at 85°C. Sterile mineral oil also
was added to prevent evaporation. The PCR reaction was carried out in a
PTC-100-CR machine (MJ Research, Watertown, MA) for 35 cycles using an
annealing temperature of 60°C, denaturing temperature of 94°C, and extension
temperature of 72°C.
PCR reaction products were digested with restriction enzymes MboI (New
England Biolabs, Beverley, MA) and EcoRI (Boehringer, Indianapolis, IN) at
37°C for 2 h. Gel electrophoresis was performed on uncut PCR product,
MboI-cut PCR product, and EcoRI-cut PCR product to verify expected size.
The uncut RT-PCR product was then sequenced in both directions using a
PCR sequencing reaction containing the 59 and 39 NEP oligonucleotide primer
and Dye Terminator with AmpliTaq DNA Polymerase FS (ABI Prism) followed
by sequencing using a model 377 Fluorescence Sequencer (ABI Prism).
Detection of PGP 9.5 mRNA in fibroblasts by northern blot analysis
Fifteen micrograms of newborn foreskin fibroblast RNA was run on a
formaldehyde gel and transferred to Hybond-N nylon membrane (Amersham,
Arlington Heights, IL) using a Vacugene apparatus (Pharmacia LKB
Biotechnology). The blot was cross-linked and the 28S and 18S bands were
marked. Twenty-five nanograms of gel-purified PGP 9.5 cDNA was labeled
with 32P-αCTP (Amersham) using the Rediprime DNA labeling system
(Amersham). The blot was prehybridized at 65°C for 1 h with Rapid-Hyb
buffer (Amersham), then hybridized with the radiolabeled probe at 65°C
for 2 h, washed at room temperature with 2 3 standard saline citrate
containing 0.1% sodium dodecyl sulfate, washed at 65°C with 0.1 3 standard
saline citrate containing 0.1% sodium dodecyl sulfate, and exposed to film
for 16 h at room temperature prior to development.
Detection of PGP 9.5 mRNA in tissue sections by RT-PCR in situ
hybridization RT-PCR in situ hybridization was performed to identify cells
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Figure 1. Nerve fibers in both the epidermis and the papillary dermis
stain positively with an antibody to PGP 9.5 in unwounded human
skin. The arrows indicate the positive PGP 9.5 staining.
containing PGP 9.5 mRNA. Six micron, formalin-fixed, paraffin-embedded
sections of chronic decubitus ulcers were deparaffinized and rehydrated in
0.53standard saline citrate followed by rinsing in RNase buffer (500 mM
NaCl, 10 mM Tris-HCl, pH 8). Sections were then digested with proteinase
K (Sigma) in RNase buffer (20 µg per ml) at 37°C for 10 min, rinsed in
0.53standard saline citrate and incubated with RQ1 RNase-free DNase (10 µl
per ml, Promega, Madison, WI) for 10 min at room temperature, and rinsed
in DEPC H2O. Slides were covered with RT reaction mixture containing the
same ingredients as described above for fibroblast RNA RT reaction. Slides
were then incubated at 42°C for 1 h in a humidified chamber, and followed
by heat inactivation of the MMLV RT at 65°C for 5 min buffer. Slides were
rinsed in sterile dH2O and placed in the PCR machine. A PCR reaction
mixture consisting of ingredients identical to those described above for the
fibroblast PCR reaction, with the exception of replacing d4NTP with biotin
16-dUTP (Boehringer) and 10 mM d3NTPs containing dATP, dGTP, and
dCTP, was added to each of the slides during the 85°C hot start and coverslipped
with rubber-sealed coverslips (Research Products International, Mount Prospect,
IL). Slides were run for 10 cycles at temperatures described above, washed in
dH2O, and rinsed in PBS. Sections were covered with avidin conjugated to
alkaline phosphatase (Dako) in 1% bovine serum albumin/PBS (1:250 dilution)
at 37°C for 1 h then washed in Triton/TBS, followed by equilibration in
TBS pH 9.5. Colorimetric development was performed using NBT/BCIP
(Boehringer) in TBS pH 9.5 for 10 min at room temperature. Reaction was
stopped by rinsing in dH2O and slides were counterstained with methyl green.
Two sets of controls were run in an identical fashion except that one set was
run without addition of primers and the other was run without addition of
MMLV RT and Taq Polymerase.
PGP 9.5 immunofluorescence and terminal deoxynucleotidyl-
transferase-mediated dUTP nick-end labeling (TUNEL) assay
To assess a role for the PGP 9.5/ubiquitin system in wound apoptosis Six micron
Figure 2. Cells in wound beds of 7 and 14 d wounds stain positively
with antibodies to PGP 9.5, ubiquitin, and PDGFb-r. Arrows indicate the
positive cellular staining. Controls without primary antibodies do not show any
cellular staining. Arrows in parts (g) and (h) indicate cells only showing the
nuclear counterstain without antibody staining.
sections of paraformaldehyde-fixed, paraffin embedded tissue were processed for
TUNEL assay according to methods outlined in the ApopTag Plus Kit (Oncor,
Gaithersburg, MD) with the following modifications: Histoclear II (National
Diagnostics, Atlanta, GA) was used in place of xylene in the deparaffinizing
process, Proteinase K (Sigma) was used at 20 µg PBS per ml, 20 min at 37°C or
50 µg PBS per ml at 32°C for 20 min, 0.00036% 4–6 diamidino-2 phenylindole
(DAPI)/TBS was applied for 3 min to counterstain nuclei, and Prolong Antifade
Kit (Molecular Probes, Eugene, OR) was used as slide mounting media. Serial
tissue sections were labeled with PGP 9.5 at 1:1500 dilution for 1 h, biotinylated
goat anti-rabbit (Vector Laboratories) at 1:400 dilution for 30 min and fluorescent
Cy 5 conjugated streptavidin (Jackson ImmunoResearch Laboratories, West
Grove, PA) at 1:1000 dilution for 30 min was used.
RESULTS
PGP 9.5 was detected in nerves and stellate cells in 7, 14, and 21 d
wounds PGP 9.5 was observed by ICC to stain cutaneous nerve fibers
in the epidermis and dermis of normal skin adjacent to the standard
wounds of all ages (Fig 1). No cellular staining was observed in 1, 2, or
3 d wounds, although staining was occasionally observed in stellate cells
adjacent to 4 d wounds. PGP 9.5 was clearly observed in the bed of 7 d
wounds in cells with morphologic features of fibroblasts (Fig 2a). By
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Figure 3. Cells in the granulation tissue from a chronic decubitus ulcer
stain positively for both PGP 9.5 and ubiquitin. Arrows indicate positive
cellular staining in the ulcer bed (a, c) for PGP 9.5 and ubiquitin, respectively.
Cells in the tissue adjacent to the ulcer (b) do not show PGP 9.5 positive
staining of stellate cells (small arrows); however, the large nerve (arrowhead) shows
positive PGP 9.5 staining. Control (d) without primary antibodies do not show
any cellular staining. Arrows in (d) indicate cells only showing the nuclear
counterstain without PGP 9.5 staining.
14 d, the cellular staining was strong in these stellate cells (Fig 2b). Similar
intensity persisted in the 21 d wounds (not shown). PGP 9.5 staining was
observed in most, but not all, of the stellate cells in the granulation tissue
of chronic ulcers (Fig 3a). Stellate cells in the dermis adjacent to the
ulcers did not show immunostaining (Fig 3b).
Ubiquitin was detected in stellate cells in 7, 14, and 21 d
wounds Similar to PGP 9.5, ubiquitin staining was observed in stellate
cells in the standard human wounds at 7, 14 (Fig 2c, d), and 21 d
(not shown), but not in earlier wounds. Likewise, ubiquitin staining of
granulation tissue from chronic decubitus ulcers was also observed
(Fig 3c).
PDGFβ-r was detected in stellate cells in 7, 14, and 21 d
wounds Immunostaining for PDGFβ-r was observed in stellate cells
of 7, 14 (Fig 2e, f ), and 21 d old wounds (not shown) but was not
observed in earlier wounds. PDGFβ-r staining was noted in endothelial
cells and pericytes adjacent to the wounds at all time points studied
(not shown).
Confocal microscopy shows PGP 9.5 is expressed by fibroblasts
(5B5 positive cells) Confocal microscopy of a 14 d wound (Fig 4)
showed further evidence that the stellate cells are fibroblasts. Some
stellate cells in the wound bed shown in Fig 4 are stained green by
immunofluorescence for PGP 9.5 (Fig 4a), whereas other stellate cells
stained red with the fibroblast marker 5B5 (Fig 4b). Some cells appear
orange on the merged confocal micrograph, indicating costaining for
PGP 9.5 and 5B5. It should be noted that not all cells staining with
antibodies to 5B5 are positive for PGP 9.5.
Confocal microscopy shows coexpression of PDGFβ-r and PGP
9.5 Figure 5 is a confocal micrograph of the same 14 d wound stained
Figure 4. Confocal microscopy of a 14 d wound shows coexpression of
PGP 9.5 and 5B5 (a fibroblast marker). (a) Immunofluorescent staining of
stellate cells for PGP 9.5 (green) and 5B5 (red). Cells staining both green and
red (orange) on this merged confocal micrograph indicate coexpression of PGP
9.5 and 5B5 as indicated by arrows. (b) Higher magnification of (a) showing
separate red and green staining in some cells, which appear orange at lower
magnification. (c, d) Control specimens without primary antibodies. Filter for
Texas Red (c); filter for FITC (d). Elastin autofluoresces in both the red and
the green channels.
with antibodies to PGP 9.5 (green) and PDGFβ-r (red). Coexpression
of the two proteins is demonstrated by costaining of the stellate cells in
this merged confocal micrograph.
TEM shows fibroblast ultrastructure for stellate cells Stellate cells
in 14 d wounds prepared for TEM include extensive rough endoplasmic
reticulum, Golgimembranes, and lack lysosomal vacuoles consistent with
fibroblasts (Fig6). These cells are closely associated withfibrillar collagen.
RT-PCR of fibroblast RNA shows PGP 9.5 cDNA A 339 bp
segment of cDNA was amplified from newborn foreskin fibroblast RNA
(Fig 7, lane 1). Restriction enzyme digestions of the PCR product were
consistent with the predicted products corresponding to the PGP 9.5
cDNA sequence 170–508 bp. Gel electrophoresis on the EcoRI-cut
PCR product yielded two bands at the expected sizes of 249 and 90 bp
(Fig 7, lane 2), and the MboI-cut PCR product yielded a doublet at the
expected sizes of 160 bp and 179 bp (Fig 7, lane 3). The DNA sequence
of the uncut PCR product was identical with the predicted sequence
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Figure 5. Confocal microscopy of a 14 d
wound shows colocalization of PGP 9.5
and PDGFb-r in stellate cells. (a) Immuno-
fluorescent staining of stellate cells for PGP
9.5 (green) and PDGFβ-r (red) as designated
by arrows. (b) At higher magnification the
cells surrounding vessels, possibly pericytes
(arrowheads) as well as stellate cells in the
wound bed (small arrows), show positive
PDGFβ-r immunofluorescent staining.
Figure 6. Transmission electron micrograph of a stellate cell from a
14 d wound bed shows morphologic features of a fibroblast. The cell
has extensive rough endoplasmic reticulum (large arrows) typical for fibroblasts,
Golgi membranes (small arrows), and collagen in the matrix surrounding the
cells (arrowheads).
corresponding to the PGP 9.5 cDNA at 170–508 bp (Day and Thomp-
son, 1987).
Northern blot analysis of fibroblast RNA shows PGP 9.5
mRNA A single band of µ1 kb was visualized with northern blotting
of newborn foreskin fibroblast RNA with the 339 bp PGP 9.5 probe.
This bandcorresponds to thepredicted intact cDNAofPGP9.5 (1014bp)
(Day and Thompson, 1987).
Figure 7. Gel electrophoresis on PGP 9.5 PCR products verifies the
appropriate size of DNA fragment. Lane 1 is the uncut PCR product for
PGP 9.5 appropriately placed for the 339 bp segment of cDNA predicted. Lane
2 is the Eco RI-cut PCR product for PGP 9.5 showing bands at µ90 and
249 bp as predicted from the known cDNA sequence for PGP 9.5. Lane 3 is
the MboI-cut PCR product for PGP 9.5 showing a doublet that corresponds to
the predicted 160 and 179 bp restriction products. Lanes M are 100 bp standards.
RT-PCR in situ hybridization shows PGP 9.5 mRNA in wounds
stained for PGP 9.5 protein RT-PCR in situ hybridization per-
formed on chronic decubitus ulcers from patients with spinal cord injuries
demonstrated marked PGP 9.5 mRNA localization in stellate cells with
morphologic features of fibroblasts within the wound bed (Fig 8b). PGP
9.5 mRNA was not detected in similar cells in the dermis distant from
the wound bed (Fig 8c). It should be noted that not all of the stellate cells
in the wound bed exhibited PGP 9.5 mRNA staining, consistent with
confocal microscopy that showed similar results for PGP 9.5 protein.
PGP 9.5 mRNA was also found in the granular cell layer of the epidermis
adjacent to wounds. Additionally, cells surrounding many blood vessels
(pericytes) both within and away from the wound bed (Fig 8b, c) were
noted to express mRNA for PGP 9.5.
TUNEL/PGP 9.5 immunofluorescence shows minimal
apoptosis in wounds This experiment was performed to evaluate the
role of PGP 9.5 in the apoptosis pathway. As expected for normal
epidermis, a few cells in the granular layer of the epidermis adjacent to
the 7, 14, and 21 d wounds showed TUNEL positive staining (Fig 9e).
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Figure 8. Chronic decubitus ulcer shows
PGP 9.5 protein and mRNA. (a) Positive
staining for PGP 9.5 protein in stellate cells
(small arrows) in the ulcer bed. (b) In situ PCR
staining of stellate cells (small arrows) using the
PCR primer to produce the 339 bp segment
of PGP 9.5 cDNA in vitro. The biotinylated
dUTP is incorporated into cells containing
mRNA for PGP 9.5. The reaction products
are black whereas the nuclei of all cells are
stained blue. (c) In situ PCR of tissue adjacent
to the ulcer bed. Note that fibroblasts are
unstained in this tissue away from the wound.
The large arrowheads in (b) and (c) show positive
cells that appear to be pericytes. (d) In situ
control without oligonucleotide PCR primers.
Small arrows show unstained stellate cells.
Figure 9. PGP 9.5 staining is not associated with apoptosis.
Immunofluorescent staining is shown for a 14 d wound with antibodies specific
for PGP 9.5 and apoptosis is determined by TUNEL assay. Low magnification
of wound bed in (a) shows PGP 9.5 positive cells. (b) Higher magnification of
the area with asterisk in (a) showing PGP 9.5 positive cells (red). (c) A low
magnification of the same region of wound bed shown in (d). In the
dermal wound bed only one TUNEL positive cell (arrow) is seen. (d) Higher
magnification of (c). (e) Two TUNEL positive granular cells (arrows) in the
epidermis of an area adjacent to the wound.
There was only one or two TUNEL positive cells for all time points in
the dermal component of the wound bed (Fig 9c, d), whereas PGP 9.5
staining cells are abundant (Fig 9a, b). Hence, our findings do not support
a role for PGP 9.5 in wound apoptosis during the time periods studied.
DISCUSSION
The staining for PGP 9.5 and ubiquitin appeared in the stellate
cells of wounds at day 7 and became more intense in day 14 and
21 wounds. Earlier wounds of 1, 2, and 3 d showed no cellular
immunostaining for PGP 9.5. It was also noted that protein staining
was limited to the wound area, whereas adjacent skin on the same
microscopic section did not show staining. Subsequent studies of
tissue from patients with chronic sacral ulcers showed stellate cells
staining for both PGP 9.5 and ubiquitin in a pattern similar to the
incised wounds.
The stellate cells expressing PGP 9.5 in wounds were identified
as fibroblasts, using the following lines of evidence: (i) the stellate
cells had morphologic features of fibroblasts by light microscopy
and ultrastructural features of fibroblasts by TEM; (ii) confocal
microscopy of immunostained sections of wound tissue from a 14 d
wound showed colocalization in the stellate cells of PGP 9.5 and
5B5, a relatively specific marker for fibroblasts (Esterre et al, 1992;
Bosseloir et al, 1994); (iii) we established that newborn foreskin
fibroblasts are capable of making mRNA for PGP 9.5, using RT-
PCR and northern blot analysis; and (iv) RT-PCR in situ
hybridization was used to demonstrate the presence of the mRNA
from PGP 9.5 in stellate cells from chronic ulcers.
It is of interest that not all stellate cells in the wound bed appear
to express mRNA and protein for PGP 9.5. This suggests that
PGP 9.5 is upregulated in fibroblasts in the wound environment
and that some, but not all, fibroblasts in wounds express PGP 9.5
at a given time period. A similar observation was made for protein
expression of ubiquitin as indicated by ICC in chronic wounds and
7–21 d standard wounds. PGP 9.5 mRNA was expressed in the
granular layer, a metabolically active zone of the epidermis as well
as in pericytes of blood vessels, in and adjacent to wounds.
Ubiquitin has long been known to play an essential role in cell
cycle regulation (Finley and Chau, 1991; Murray, 1995; Ciechanover,
1994). It has been shown recently in human fibroblasts that the
expression of mRNA for p27 (an inhibitor of cyclin-dependent
kinases) is constant and that the level of p27 protein is regulated
by the level of ubiquitin in cells (Pagano et al, 1995). A decrease
in the level of p27 results in cell division. Therefore, specific
proteolysis of p27 may represent one mechanism in wound fibroblasts
by which the ubiquitin regulates the activity of cell division. One
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would expect to see increased ubiquitin expression in the early
phases of wound healing with this mechanism because it would be
inducing fibroblast proliferation. In this study neither ubiquitin nor
PGP 9.5 was detected in the early wounds with the ICC methods,
whereas we did observe these proteins in the later phases of repair
using ICC.
We observed PDGFβ-r by ICC in stellate cells at 7, 14, and
21 d after wounding. We demonstrated by confocal microscopy
coexpression of the PDGFβ-r and PGP 9.5 in stellate cells in 14
and 21 d wounds. We noted staining of PDGFβ-r in endothelial
cells and pericytes at earlier time points (1, 2, and 3 d) adjacent to
the wounds as previously reported by Reuterdahl et al (1993).
Antoniades et al (1991) reported PDGFβ-r mRNA expression in
fibroblasts of partial thickness porcine wounds as well as a PDGF
receptor-like protein on ICC by day 1 post-wounding. Antoniades
et al (1991) did not examine time points after 9 d. Neither
Antoniades et al (1991) nor Reuterdahl et al (1993) used other
methods to identify fibroblasts in the wound bed. In our study
both TEM and ICC using the 5B5 marker were used to identify
fibroblasts in the wound bed.
PDGF is a well-known connective tissue mitogen that also
stimulates the production of the connective tissue matrix in wounds
(Ross et al, 1986). Ubiquitinization is important for efficient
lysosomal degradation of the PDGFβ-r/ligand complex (Mori et al,
1992). As a ubiquitin C-terminal hydrolase, PGP 9.5 cleaves
ubiquitin from proteins targeted for degradation and allows ubiquitin
to be recycled within the cell. The coexpression of PGP 9.5 and
PDGFβ-r in more mature wounds suggests that the ubiquitin system
may facilitate the degradation of the PDGFβ-r/ligand complex and
thus participate in turning off the PDGF mediated fibroblast
proliferation and matrix production. Mori et al (1995) have also
shown ligand induced ubiquitinization of other tyrosine kinase
receptor subfamilies. All the monomeric receptor tyrosine kinases
examined were found to be ubiquinated after ligand stimulation,
including platelet derived growth factor alpha-receptor, epidermal
growth factor receptor, fibroblast growth factor-receptor, and colony
stimulation factor-1 receptor (CSF-1R). Like the PDGFβ-r/ligand
complex, degradation of each of these complexes could lead to a
downregulation of cellular responses in the wound-healing
cascade. We are currently investigating whether expression of the
PGP 9.5/ubiquitin system is altered in situations of excess
connective tissue production after wounding, such as keloids and
hypertrophic scars.
Others have reported a significant level of apoptosis in maturing
granulation tissue of rodents (Desmoulie`re et al, 1995; Darby et al,
1997; Brown et al, 1997). In normal rats apoptosis of fibroblasts
was most increased in the wound bed at 16–25 d (Desmoulie`re
et al, 1995). In normal mice the data were directly contradictory
regarding apoptosis within the first 14 d (Darby et al, 1997; Brown
et al, 1997). We tried to relate apoptosis to expression of PGP 9.5.
We carefully controlled for artifactual DNA degradation or masking
of binding sites due to fixation and processing conditions in the
TUNEL assay (Lucassen et al, 1995; Strater et al, 1995; Negoescu
et al, 1996). After correction for autofluorescence by use of specific
filters with a microscope and deconvolution software, we found
very little evidence of apoptosis in 7, 14, and 21 d human wounds.
The same wound area on adjacent tissue sections showed widespread
ICC staining for PGP 9.5. Hence, our findings do not support a
role for the PGP 9.5/ubiquitin system in wound apoptosis during
the time periods studied. The absence of apoptosis in 7 and 14 d
wounds was consistent with findings in the normal rodent studies.
The absence of apoptosis in the 21 d human wounds may reflect
a difference in the rate of human and rodent wound maturation
or a difference in methods for assessing apoptosis. The DNA
fragmentation labeling techniques used for assessing apoptosis are
subject to variation based on differences in tissue processing and
pretreatment, such as fixative selection, duration of fixation,
proteolytic digestion, and microwave irradiation (Lucassen et al,
1995; Strater et al, 1995; Negoescu et al, 1996).
In summary, PGP 9.5 and ubiquitin were observed in fibroblasts
during the granulation tissue and remodeling phases of wound
healing. The expression of these degradative proteins in the later
phases of wound healing is consistent with a downregulation
function for ubiquitin and PGP 9.5 in the wound healing response.
Apoptosis did not appear to be a significant mechanism for
downregulation of fibroblasts in the human wounds studied.
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